To: faro who wrote (19229 ) 6/6/2000 11:13:00 AM From: pallmer Respond to of 77509
Faro, J'ai seulement une news d'hier sur ce titre. Pallmer DJ Human Genome/Merrill -2: All Genomics Stks Up >HGSI NEW YORK (Dow Jones)--Human Genome Sciences Inc. (HGSI) stock gained ground Monday after Merrill Lynch analyst Todd Nelson issued a bullish note on the company. Nelson raised his rating on the company, based in Rockville, Md., to long-term buy from long-term accumulate. His 12-month price target is $150. Human Genome Sciences shares recently traded at 115 1/4, up 9 5/16, or 8.8%, on volume of 852,900 compared with a daily average 2.2 million. In his research report, Nelson offered four reasons for his positive outlook: "progress in clinical trials, a rapidly expanding discovery and pre-clinical pipeline, technology alliances, and the potential for 'remonetization' of assets following the completion of the SmithKline Beecham PLC (SBH) collaboration of June 30, 2001." Other genomic stocks rose in tandem with the positive outlook from Merrill. Shares of PE Corp.-Celera Genomics Group (CRA) recently were up 9 13/16, or 14/3%, at 78 5/16. Shares of Genome Therapeutics Corp. (GENE) were up 2 1/4, or 13.4%, at 19. Shares of Gene Logic Inc. (GLGC) were up 2, or 7.2%, at 29 5/8. Shares of Sequenom Inc. (SQNM) were up 2, or 7.5%, at 28 1/2. -Laura Elizabeth Pohl, Dow Jones Newswires; 201-938-5392 (END) DOW JONES NEWS 06-05-00 10:31 AM- - 10 31 AM EDT 06-05-00 Jun-05-2000 14:36 GMT Symbols: US;CRA US;GENE US;GLGC US;HGSI US;SQNM Source DJ Dow Jones Categories: I/BTC I/ICS I/ISO I/MTC I/SVC SUB/DJN N/DJN SUB/DJWI N/DJWI SUB/DJS N/DJS SUB/MMM N/MMM SUB/STK N/STK M/IDU M/NND M/TEC P/DIG P/DPH GEO/CAL R/CAL GEO/CT R/CT GEO/MA R/MA GEO/MD R/MD GEO/NME R/NME GEO/PRM R/PRM GEO/US R/US GEO/USE R/USE GEO/USW R/USW